In a recent legal move, Attorney General Anne Lopez, along with a coalition of attorneys general from 17 states and Washington, D.C., urged a federal judge in Spokane, Washington, to reconsider the FDA's longstanding restrictions on the abortion pill mifepristone, highlighting the safe use of the drug by over 5.6 million patients since its approval in 2000, as reported by the office of the Hawaiian Governor. While the FDA imposes extra restrictions called Risk Evaluation and Mitigation Strategy (REMS) and Elements to Assure Safe Use (ETASU) on a limited number of drugs, critics argue that mifepristone's safety profile doesn't warrant such stringent controls.
Representing Hawaii in this multistate lawsuit, Deputy Attorney General Erin Lau expressed, "Since 2000, more than 5.6 million patients have safely used mifepristone. We should not be afraid to increase access to a medication whose safety and efficacy is based in science and proven over time. Artificial limitations on safe and effective medication are actual limitations on access to healthcare." a statement obtained by the office of the Hawaiian Governor. The FDA's stringent regulations on mifepristone stand out, especially when the drug's safety profile is compared to widely accepted medications.
The ongoing lawsuit asserts the current rules surrounding the prescription and dispensing of mifepristone are not only unnecessary and excessively heavy-handed but also pose risks to patient privacy and safety amidst the increasing criminalization of abortion. The argument stems from the aftermath of the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, which effectively dismantled the constitutional protection for abortion previously affirmed by Roe v. Wade.
In a recent motion for summary judgment, the coalition of plaintiff states has asked the court to compel the FDA to reassess whether the drug still fits the stringent criteria for REMS with ETASU, suggesting the abundance of data supporting the medication's safety and effectiveness; additionally, they claim medical authorities have long been at odds with these restrictions, pointing out to the unnecessary limitations this places on a drug deemed safer than over-the-counter medications like Tylenol, according to the filing provided by the Hawaiian Governor's office.
The legal challenge is crucial for expanding access to mifepristone, which could affect how healthcare providers prescribe and dispense treatments for both abortions and miscarriages. Attorneys general from states like Arizona, Colorado, and Maine, along with Attorney General Lopez, are involved in the lawsuit, showing a strong collaboration to change federal health policy.
